Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II/III and successful prenatal diagnosisopen access
- Authors
- Yang, M.[Yang, M.]; Cho, S.Y.[ Cho, S.Y.]; Park, H.-D.[Park, H.-D.]; Choi, R.[ Choi, R.]; Kim, Y.-E.[ Kim, Y.-E.]; Kim, J.[ Kim, J.]; Lee, S.-Y.[Lee, S.-Y.]; Ki, C.-S.[Ki, C.-S.]; Kim, J.-W.[Kim, J.-W.]; Sohn, Y.B.[ Sohn, Y.B.]; Song, J.[ Song, J.]; Jin, D.-K.[Jin, D.-K.]
- Issue Date
- 17-Jan-2017
- Publisher
- BIOMED CENTRAL LTD
- Keywords
- GNPTAB; Lysosomal storage disease; Mucolipidosis; Prenatal diagnosis
- Citation
- ORPHANET JOURNAL OF RARE DISEASES, v.12
- Indexed
- SCIE
SCOPUS
- Journal Title
- ORPHANET JOURNAL OF RARE DISEASES
- Volume
- 12
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/30477
- DOI
- 10.1186/s13023-016-0556-2
- ISSN
- 1750-1172
- Abstract
- Background: Mucolipidosis types II and III (ML II/III) are autosomal recessive disorders caused by a deficiency in the lysosomal enzyme N-acetylglucosamine-1-phosphotransferase. We investigated the molecular genetic characteristics of the GNPTAB gene, which codes for the alpha/beta subunits of a phosphotransferase, in Korean ML II/III patients. We included prenatal tests and evaluated the spectrum of mutations in East Asian populations with ML II/III through a literature review. Methods: Seven patients from six families were enrolled in the study including two prenatal tests using chorionic villi samples. A diagnosis of ML II/III was made based on clinical findings and increases in serum lysosomal enzyme levels. PCR and direct sequencing were performed to identify GNPTAB mutations. Results: We found 14 mutant alleles including seven known mutations of c.2189delT (p.Leu730fs* 7), c.1090C > T (p.Arg364*), c.2681G > A (p.Trp894*), c.3565C > T (p.Arg1189*), c.310C > T (p.Gln104*), c.1071G > A (p.Trp357*) and c.2574_2575delGA (p.Asn859Glnfs* 2). Four were novel variants of unknown significance: c.992A > G (p.Tyr331Cys), c. 666 T > A (p.Leu889*), c.637-6 T > G (p.Thr213Phefs* 11), and c.471_472delTT (p.Tyr158Serfs* 8). Family studies revealed the probands to be compound heterozygotes. The fetuses carried the same GNPTAB mutations as the mucolipidosis II/III probands in the prenatal diagnosis. Conclusions: We identified GNPTAB mutations in all patients with ML II/III, but did not identify a hot spot in Korean patients. We successfully performed prenatal diagnosis using molecular investigation.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.